Irina Andreevna Bulavina

Irina Andreevna Bulavina

Auto-generated profile, based on publicly available information

Irina Andreevna Bulavina

Moscow City Clinical Hospital in honor of V.M. Buyanov

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2023 in Journal of Clinical Practice
Verified
Journal Article
Open access
PDF file
AZAleksandr S. Zotov
Aleksandr S. Zotov
IKIgor A. Khamnagadaev
Igor A. Khamnagadaev
ESEmil R. Sakharov
Emil R. Sakharov
OSOleg O. Shelest
Oleg O. Shelest
LBLeonid A. Belousov
Leonid A. Belousov
ATAleksandr V. Troitskiy
Aleksandr V. Troitskiy
Background: Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and is associated with an increased risk of death, progression of heart failure, and the development of cardiogenic thromboemboli. Despite the significant success in the management of AF in the paroxysmal form, the results of the treatment for patients with persistent forms of AF remain unsatisfactory. Though the surgical approach provides higher rates of efficiency regarding the restoration of a sinus rhythm, transmural lesions are not always attainable, as a result, the rate of AF recurrence in the long-term period remains fairly high. It is also impossible to create ablative patterns to the mitral and tricuspid valves during thoracoscopic epicardial ablation, which can cause the development of recurrent AF, perimitral and typical atrial flutter. Therefore, the development of hybrid approaches combining the advantages of catheter and thoracoscopic techniques is an urgent task of contemporary surgical and interventional arrhythmology. Aims: to estimate the immediate results of a hybrid approach in the management of patients with persistent AF. Methods: We report the first experience of a hybrid treatment of patients with persistent AF. 6 patients aged 53-64 years (1 female, 5 males) were included in the study. At the first stage, thoracoscopic epicardial bipolar ablation was performed (modified GALAXY protocol); the second stage (in 3 to 6 months after the thoracoscopic stage) included an intracardiac electrophysiological study with three-dimensional endocardial mapping followed by endocardial ablation. Results: The thoracoscopic stage of the hybrid treatment included ablation according to the box lesion scheme using a bipolar irrigation equipment. No lethal outcomes and severe, life-threatening complications were registered. The duration of the inpatient period was 510 hospital-days. The 2nd stage of the hybrid treatment was limited to intracardiac electrophysiological examination only in 2 patients. In 4 patients, epicardial radiofrequency ablation was complemented by endocardial radiofrequency exposure. In 3 of the 4 patients who underwent endocardial radiofrequency ablation, catheter ablation of the mitral and cavotricuspid isthmus was required because of the induction of perimitral and typical flutter, respectively. After the 2nd stage of the hybrid treatment, at the time of discharge all the patients maintained a stable sinus rhythm. There were no severe complications or lethal outcomes. Conclusion: a hybrid approach in the AF management is a safe and effective method of treatment, which combines the advantages of minimally invasive surgery and endocardial intervention in patients with persistent AF. The technique is safe and has acceptable short-term results.

9 January 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
IBI. A. Bulavina
I. A. Bulavina
YVYu. D. Vaisman
Yu. D. Vaisman
ABAzamat Baymukanov
Azamat Baymukanov
MYM. V. Yunyaeva
M. V. Yunyaeva
III. L. Ilyich
I. L. Ilyich
ЮВЮ. Д. Вайсман
Ю. Д. Вайсман
In recent decades, there has been increased interest in obstructive sleep apnea (OSA), especially in patients with a combination of OSA and sleep bradyarrhythmias. Worldwide, the diagnosis of OSA is steadily increasing. Increasingly, clinicians have begun to use CPAP therapy to treat sleep-related bradyarrhythmias. But in world practice there are no unambiguous guidelines for the management of this group of patients.

18 January 2025 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
IKI. A. Khamnagadaev
I. A. Khamnagadaev
AZA. S. Zotov
A. S. Zotov
OSO. O. Shelest
O. O. Shelest
IBI. A. Bulavina
I. A. Bulavina
AGA. A. Glupak
A. A. Glupak
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
BACKGROUND: Treatment of patients with diabetes mellitus (DM) and a long-term persistent form of atrial fibrillation (AF) is an unsolved problem of the healthcare system due to a high risk of disability and mortality. Considering low effectiveness of drug treatment for AF, surgical technologies have been introduced into clinical practice in most countries, but their effectiveness has not been validated for patients with DM. According to various researches isolated interventional treatment of patients with AF and DM is associated with a high rate of recurrence compared to patients without disorders of carbohydrate metabolism. The feasibility of using other surgical approaches (the isolated thoracoscopic procedure or the isolated thoracoscopic procedure in combination with intracardiac intervention) for the treatment of AF for patients with DM has not been determined yet.AIM: To evaluate the effectiveness and safety of a staged surgical approach to release patients with DM from AF.MATERIALS AND METHODS: The study included 19 patients aged 53–73 with DM and long persistent AF. Among them there were 4 (21,4%) women and 15 (78,9%) men. To maintain sinus rhythm all patients were undergone with thoracoscopic epicardial ablation. In three mounts, later the invasive electrophysiological studies and radiofrequency ablation were carried out due to reconnection of left atrium (LA).RESULTS: At the end of the blinded period sinus rhythm was maintained for 17 (89,5%) patients during the observation period. Two patients (10.5%) had AF recurrence. In both cases, the second stage of treatment wasperformed (electrophysiology study and endocardial ablation). Amid normal sinus rhythm after thoracoscopic epicardial ablation the volume of the LA (p=0,013) and the N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (p=0,014) significant decreased. No adverse events were recorded in the perioperative or long-term periods.CONCLUSION: Аccording to our pilot study, the staged approach to surgical maintenance of sinus rhythm for patients with diabetes and persistent form of atrial fibrillation can be an optimal strategy. The endocardial stage could be performed for this category of patients in case of recurrence of tachysystolic cardiac arrhythmias.

11 April 2023 in Journal of Clinical Practice
Verified
Journal Article
Open access
PDF file
IBIrina A. Bulavina
Irina A. Bulavina
IKIgor I. Khamnagadaev
Igor I. Khamnagadaev
MKMikhail L. Kokov
Mikhail L. Kokov
ATAleksandr V. Troitskiy
Aleksandr V. Troitskiy
AZAleksandr S. Zotov
Aleksandr S. Zotov
MSMaria A. Shkolnikova
Maria A. Shkolnikova
The specifics of the anticoagulant therapy after radiofrequency ablation of the cavotricuspid isthmus have not been sufficiently studied, therefore, the recommendations for prescribing the anticoagulant therapy usually do not distinguish between atrial flutter and atrial fibrillation. In contrast to the case of atrial fibrillation, the effectiveness of the interventional treatment for typical atrial flutter reaches 90%. This procedure may save the patient from a long-term anticoagulant therapy in the absence of recurrence of typical atrial flutter. The decision to stop the anticoagulant therapy after successful radiofrequency ablation of the cavotricuspid isthmus should take into account the potential induction of atrial fibrillation in patients undergoing the interventional treatment. In addition to the CHA2DS2-VASc scale, which characterizes the patient's comorbidity, it is important to take into account the echocardiographic morphofunctional criteria to assess the risk of atrial fibrillation. Currently, this protocol is not regulated in the clinical guidelines. The analysis of the literature data and the authors' own experience allow us to conclude that the optimal time for stopping the anticoagulant therapy is a relapse-free period of 34 months after the radiofrequency ablation of the cavotricuspid isthmus, since it is at this time that the effectiveness of the interventional treatment can be objectified.

26 December 2025 in Cardiosomatics
Verified
Journal Article
Open access
AMAnastasia S. Myasnikova
Anastasia S. Myasnikova
IBIrina Z. Bondarenko
Irina Z. Bondarenko
OSOlga A. Shatskaya
Olga A. Shatskaya
IKIgor A. Khamnagadaev
Igor A. Khamnagadaev
LBLeonid A. Belousov
Leonid A. Belousov
MSMarina Shestakova
Marina Shestakova
BACKGROUND: Diabetes mellitus (DM), atrial fibrillation (AF), and atrial flutter (AFL) are among the most prevalent cardiovascular disorders, with their incidence steadily increasing worldwide. The coexistence of DM with AF or AFL is associated with a more severe disease course and a less favorable prognosis compared with each condition occurring independently. AIM: To analyze current clinical and epidemiological aspects of atrial fibrillation (AF) and atrial flutter (AFL) in patients with diabetes mellitus, including sex- and age-related characteristics, distribution by subtype, and the relationship between diabetes mellitus and outcomes after radiofrequency catheter ablation. METHODS: A retrospective analysis of medical records was performed for patients hospitalized in the cardiology department of the National Medical Research Center for Endocrinology named after Academician I.I. Dedov (Moscow, Russia) between January 1, 2017, and October 30, 2025. RESULTS: Among the analyzed discharge summaries, 218 patients (24.9%) had type 2 diabetes mellitus. Of these patients, 30.7% had paroxysmal AF, 22.5% persistent AF, 15.1% persistent AF combined with AFL, 12.8% persistent AFL, 12.4% paroxysmal AF combined with AFL, and 6.5% paroxysmal AFL. Comparative analysis of patient groups with and without diabetes mellitus did not demonstrate convincing evidence of an effect of impaired carbohydrate metabolism on the outcomes of radiofrequency catheter ablation. CONCLUSION: This study clearly demonstrates the prevalence of diabetes mellitus among patients with AF and AFL and identifies criteria for further investigation of the impact of diabetes mellitus on the outcomes and progression of AF. Further study of this issue is required.

17 February 2025 in Russian Medicine
Verified
Journal Article
Closed access
MYMaria V. Yunyaeva
Maria V. Yunyaeva
IBIrina Andreevna Bulavina
Irina Andreevna Bulavina
ABAzamat Baymukanov
Azamat Baymukanov
YWYuliya Weissman
Yuliya Weissman
AEArtem Anatolyevich Evmenenko
Artem Anatolyevich Evmenenko
ВДВайсман Юлия Дмитриевна
Вайсман Юлия Дмитриевна
BACKGROUND: Obstructive sleep apnea (OSA) is associated with various cardiovascular diseases, including arterial hypertension, chronic heart failure, and cardiac rhythm and conduction disorders. In some patients, preexisting bradycardia may not be directly related to OSA. Therefore, it is advisable to rule out OSA in patients referred for pacemaker implantation. CLINICAL CASES DESCRIPTION: OSA is a common condition frequently associated with bradyarrhythmias. In some cases, treatment for such patients involves the implantation of a permanent endocardial pacemaker. Undiagnosed OSA may lead to an increased number of unnecessary pacemaker implantations, emphasizing the importance of timely diagnosis and treatment of this condition. This article presents clinical observations of seven patients with nocturnal bradyarrhythmias, which resolved following continuous positive airway pressure (CPAP) therapy. The use of CPAP therapy contributed to the improvement of cardiovascular parameters, including the reduction in the number and duration of heart rhythm pauses. Clinically significant bradyarrhythmias were resolved in patients, allowing them to avoid surgical intervention. In the described cases, patients demonstrated a high apnea–hypopnea index (35.0–79.5 episodes per hour), a significant decrease in blood oxygen saturation (minimum up to 50%), and significant heart rhythm disturbances during the night. The initiation of CPAP therapy led to a reduction in the apnea–hypopnea index (1.9–23.1 episodes per hour), normalization of minimum oxygen saturation (80–93%), and the elimination of prolonged rhythm pauses. CONCLUSION: The findings highlight the necessity of mandatory screening for OSA in patients with nocturnal bradyarrhythmias before planning pacemaker implantation. CPAP therapy effectively eliminates rhythm disturbances associated with sleep apnea and prevents unnecessary surgical procedures. This confirms the importance of a comprehensive approach to the diagnosis and treatment of this category of patients and the need for further large-scale studies to optimize their management tactics.